638218-70-9Relevant articles and documents
Novel and convenient synthesis of benzofurans from dihydrocoumarins
Shachan-Tov, Sharona,Frimer, Aryeh A.
, p. 905 - 908 (2012)
7-Hydroxy-3,4-dihydrocoumarin-4-carboxylic acid (7), conveniently prepared from m-resorcinol and maleic anhydride, was surprisingly transformed by acid anhydride and pyridine into the corresponding ketone, 4-alkanoyl analog 11. The latter reacted in turn
Metal and oxidant-free Br?nsted acid-mediated cascade reaction to substituted benzofurans
Mari, Giacomo,Ciccolini, Cecilia,De Crescentini, Lucia,Favi, Gianfranco,Santeusanio, Stefania,Mancinelli, Michele,Mantellini, Fabio
, p. 10814 - 10824 (2019)
Substituted hydroxy-benzofurans are easily accessible by treatment of resorcinols and 1,2-diaza-1,3-dienes (DDs) under acidic conditions. The reaction happens through an uncommon Michael reaction between aromatic derivatives as aromatic C(sp2)-
Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
-
, (2008/06/13)
The invention relates to compounds represented by the formula I and to prodrugs or metabolites thereof, or pharmaceutically acceptable salts or solvates of said compounds, said prodrugs, and said metabolites, wherein Z, Y, R11 and R14, R15, R16, and R17 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.
BENZOFUSED HETEROARYL AMIDE DERIVATIVES OF THIENOPYRIDINES USEFUL AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS INCLUDING THE SAME, AND METHODS FOR THEIR USE
-
Page 122, (2010/02/04)
The invention relates to compounds represented by the formula I and to prodrugs or metabolites thereof, or pharmaceutically acceptable salts or solvates of said compounds, said prodrugs, and said metabolites, wherein Z, Y, R11 and R14, R15, R16, and R17 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.